株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

先進創傷ケア製品の世界市場

The Global Market for Advanced Wound Care Products 2014

発行 Espicom Business Intelligence 商品コード 316056
出版日 ページ情報 英文 281 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
先進創傷ケア製品の世界市場 The Global Market for Advanced Wound Care Products 2014
出版日: 2016年06月01日 ページ情報: 英文 281 Pages
概要

当レポートでは、世界の先進創傷ケア製品市場について調査し、市場概要の分析、背景情報、先進創傷ケア製品・技術に関する情報、および主要メーカーのプロファイルなどを提供しています。

市場概要

  • エグゼクティブサマリー

背景

  • 創傷ケア製品
  • 先進創傷ケア
  • 現在の市場力学
  • 地域別の展望
  • 競合環境
  • 将来の市場展望

先進創傷ケア製品&技術

  • デバイスベースの創傷ケア
    • 陰圧創傷治療
    • 電気刺激
    • 超音波
    • 体外衝撃波療法
    • その他の創傷ケアデバイス

湿潤創傷ケア製品

  • ヒドロゲル
  • ハイドロコロイド被覆材
  • フォーム被覆材
  • 複合被覆材
  • ソフトシリコン被覆材
  • 活性炭被覆材
  • 透明膜被覆材
  • 抗菌被覆材

生物製剤

  • 市場力学
  • 規制環境
  • コラーゲンベースの創傷ケア製品
  • 代用皮膚
  • 成長因子
  • 細胞ベース療法
  • その他の生物学的製品
  • 酵素デブリードメント

創傷ケアメーカー

  • 市場リーダー
  • その他の企業

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

In 2015, the global woundcare market is estimated to have been worth approximately US$6.6 billion, having increased by around 3.5% over the previous year. Currently, growth is being hampered by pricing pressure due to intensifying competition in all product sectors and the impact of government efforts to curb healthcare spending as part of deficit reduction measures.

Although pricing pressure is expected to impact the market in the short to medium term, growth is predicted, driven by favourable demographic factors that are increasing demand, as well as demand in emerging markets and new product innovation.

Given the fragmented nature of the advanced wound care market and the number of private companies operating in this area, it can be challenging to quantify the market. Wound care companies do not break down their sales into different product types, making it difficult to assess the value of each area. However, based on all available data and consensus estimates, Espicom conservatively estimates that the total market was worth US$6.6 billion in 2015.

While the advanced wound care market saw double-digit growth before 2008, it has slowed more recently. The number of patients requiring treatments for chronic and challenging wounds has risen, driven by the increasing number of older patients and those with conditions such as diabetes. However, growth has been affected by intense competition that brought down selling prices and declines in reimbursement levels as governments seek to rein in healthcare expenditure.

The moist wound dressings market is a relatively mature area and many of the market-leading products have been offered for some years, leading to strong brand recognition and user-friendliness for caregivers. This market has experienced weak pricing since 2009, particularly in Europe. However, growth is coming from increasing adoption in the US and emerging markets, the development of new composite products that offer advancements over earlier products and increased demand for advanced wound care products in general.

Having seen strong market growth over many years, the market for NPWT products declined in 2012, growth was flat in 2013, and the market declined again in 2014 and 2015. This has mainly been due to lower pricing as a result of increased competition globally, and reductions in reimbursement in the US.

The biologics products market is characterised by more innovation than any other sector of the advanced wound care market, although this is the smallest segment of the industry and barriers to market entry are the highest. Many products have to go through the more stringent FDA PMA or NDA processes, involving significant costs and time for potential market entrants, which are often development-stage companies with limited resources. These products can also often mean a change of practice for users and a higher cost than older products, which impacts adoption rates and therefore the development of this market.

Table of Contents

MARKET OVERVIEW

  • EXECUTIVE SUMMARY

BACKGROUND

  • WOUND CARE PRODUCTS
    • Advanced Wound Care
      • Complex Wounds: The Role of Advanced Wound Care
        • Diabetic Foot Ulcers
        • Pressure Ulcers
        • Venous Stasis Ulcers
  • CURRENT MARKET DYNAMICS
    • Establishing Safety and Effectiveness
    • Regulatory Environment
  • REGIONAL PERSPECTIVE
  • COMPETITIVE ENVIRONMENT
    • Changing Industry Landscape
  • FUTURE MARKET PROSPECTS

ADVANCED WOUND CARE PRODUCTS & TECHNOLOGIES

  • DEVICE-BASED WOUND CARE
    • Negative Pressure Wound Therapy
      • Competitive Environment
      • Market Dynamics
      • Acelity (Kinetic Concepts) NPWT Products
        • V.A.C. Therapy
        • Nanova NPWT System
        • SNaP NPWT Products
      • Smith & Nephew's NPWT Systems
        • RENASYS Products
        • PICO
      • Cardinal Health's NPWT Systems
      • Devon Medical's extriCARE NPWT System
      • Genadyne Biotechnologies' A4 and XLR8 NPWT Systems
      • Hartmann's Vivano NPWT System
      • Integrated Healing Technologies' NewEra NPWT System
      • Lohmann & Rauscher's Suprasorb CNP
      • Medela's Invia Liberty NPWT System
      • Mölnlycke Health Care's Avance NPWT Systems
      • Prospera's PRO NPWT Systems
      • Talley Group's Venturi Systems
      • The Medical & WoundCare Company's Exsudex
    • Electrical Stimulation
      • Synapse Electroceutical's Accel-Heal
      • Vomaris Innovations' Procellera
        • Clinical Studies
    • Ultrasound
      • Arobella Medical's Qoustic Wound Therapy System
      • Celleration's MIST Therapy
      • Misonix' SonicOne Ultrasonic Wound Debridement System
      • NanoVibronix' PainShield and WoundShield
      • Söring's Sonoca Systems
    • Extracorporeal Shockwave Therapy
      • SANUWAVE's dermaPACE
        • Patents
        • PMA Studies
    • Tissue Regeneration Technologies' DermaGold
    • Other Wound Care Devices
      • Regenesis Biomedical's Provant Wound Therapy System

MOIST WOUND CARE PRODUCTS

  • Hydrogels
    • ULURU's Nanoflex Technology
  • Hydrocolloid Dressings
  • Alginates
  • Foam Dressings
    • Key and New Foam Technologies
      • Acelity's Tielle Foam Dressings
      • ConvaTec's AQUACEL Foam Dressings
      • Crawford Healthcare's KerraFoam Gentle Border
      • Coloplast's Biatain
      • DermaRite Industries' ComfortFoam Border Lite
      • Hartmann's HydroTac Products
      • Lohmann & Rauscher's Suprasorb P
      • Mölnlycke Health Care's Mepilex Border Dressings
      • Smith & Nephew's Allevyn Dressings
    • Composite Dressings
      • 3M Tegaderm Matrix Dressing with PHI technology
      • Crawford Healthcare's KerraFibre
      • ConvaTec's AQUACEL
      • Medline's Opticell
      • Urgo's Lipido-Colloid Technology Dressings
        • Super-Absorbent Dressings
    • Soft Silicone Dressings
    • Activated Charcoal Dressings
    • Transparent Film Dressings
    • Antimicrobial Dressings
      • Silver Dressings
        • Acelity/Systagenix' Silvercel and Actisorb Silver 220
        • Argentum Medical's Silverlon
        • ConvaTec's AQUACEL Ag Products
        • Crawford Healthcare's KerraContact Ag with Oxysalt Technology
        • Medline's Opticell Ag+
        • Milliken Chemical's AFM Dressings
        • Noble Biomaterials' SilverSeal and X-STATIC Technology
        • Smith & Nephew's Acticoat Dressings
        • Smith & Nephew's Other Silver Dressings
      • Honey Dressings
        • Derma Sciences/Comvita's Medihoney
        • Triticum's L-Mesitran Range
      • Iodine-based Dressings
      • PHMB Antimicrobial Dressings
      • Other Antimicrobial Dressings
        • 3M's Tegaderm CHG
        • BSN medical's Cutimed Sorbact Hydroactive
        • Derma Sciences' Dermagran
        • Hollister/Hydrofera's Hydrofera Blue
        • Oculus Innovative Sciences' Microcyn Technology
        • Phytoceuticals' 1 PRIMARY WOUND DRESSING
      • Other Products In Development
        • Innocoll's Cogenzia

BIOLOGICS

  • Market Dynamics
  • Regulatory Environment
  • Collagen-Based Wound Care Products
    • Acelity/Systagenix Collagen-Based Dressings
    • Gentell's Gentell Collagen
    • Collagen Matrix' Matrix Collagen Dressing
    • Covalon Technologies' ColActive
    • Eucare Pharmaceuticals
    • Hartmann's CollaSorb
    • Human BioSciences' SkinTemp II and Medifil II
    • Lescarden's Catrix Wound Dressing
    • Olympus Terumo Biomaterials' Terudermis Artificial Dermis
    • MedSkin Solutions Dr Suwelack's ProHeal Bio-Active Wound Therapy and Puracol Plus
    • Organogenesis' PuraPly
    • Taxus Cardium Therapeutics' Excellagen
      • Research & Development
      • Clinical Studies
    • Wound Management Technologies' CellerateRx
    • Products in Development
      • Innocoll's Cogenzia
  • Skin Substitutes
    • Changes to CMS Reimbursement
    • Acelity/LifeCell's Graftjacket
    • ACell's Products
      • Study Results
    • Anika Therapeutics' HYAFF
    • Derma Sciences' AMNIOEXCEL and AMNIOMATRIX
    • Medline Industries' Revitalon
    • Integra LifeSciences' Collagen-Glycosaminoglycan Matrix
      • Integra Omnigraft Dermal Regeneration Matrix
    • Integra/TEI Biosceinces' PriMAtrix
    • Medestea Internazionale's Veloderm
    • MedSkin Solutions Dr Suwelack's Matriderm
    • MiMedx' EpiFix
      • FDA Letter
      • Clinical Trial Results
    • Organogenesis' Apligraf
    • Organogenesis' Dermagraft
      • Diabetic Foot Ulcer Health Economics Model
    • Osiris Therapeutics' Grafix
      • Clinical Studies
    • Osiris Therapeutics' TruSkin
    • PolyNovo Biomaterials' NovoSorb
      • NovoSorb BTM for Surgical Wounds
      • NovoSorb BTM for Burns
    • NovoSorb TNP Dressing
    • Promethean LifeSciences' GammaGraft and Repriza
    • Smith & Nephew/Cook Biotech's Oasis Wound Matrix Products
    • UDL Laboratories/S&N's Biobrane
    • Vericel's Epicel Cultured Epidermal Autografts
  • Growth Factors
    • Kaken Pharmaceutical's Fiblast Spray
    • Smith & Nephew's Regranex (becaplermin) Gel 0.01%
    • Products in Development
    • Autologous Growth Factor Products
      • Nuo Therapeutics' Aurix System
  • Cell-Based Therapies
    • Avita Medical's ReCell and ReGenerCell
      • ReCell Spray-On Skin
      • ReGenerCell
    • Products in Development
      • Osiris Therapeutics' OTI-15-01
      • RegeneRx' RGN-137
  • Other Biologic Products
    • Biotec Pharmacon's Woulgan Biogel
  • Enzymatic Debriding Agents
    • Smith & Nephew's Collagenase Santyl Ointment
    • Maggot Therapy
    • Lohmann & Rauscher's Debrisoft
    • MediWound's NexoBrid
    • In Development - MediWound's EscharEx

WOUND CARE MANUFACTURERS

  • THE MARKET LEADERS
    • 3M
      • Current Alliances
        • Kinetic Concepts
        • The Woundcare Company
    • Acelity
      • NPWT
        • V.A.C. Therapy
        • SNaP NPWT Products
        • Nanova NPWT System
      • CelluTome Epidermal Harvesting System
      • Advanced Wound Dressings
      • LifeCell Products
      • Current Alliances and Contracts
        • Mediq
        • US Department of Veterans Affairs
        • Noble Biomaterials
        • Wright Medical Group
        • 3M
      • Financial Performance
    • Coloplast
      • Financial Performance
    • ConvaTec
      • Wound Care Product Portfolio
      • Litigation with Smith & Nephew
      • Financial Performance
    • Hartmann Group
      • Advanced Wound Care Products
        • Vivano NPWT System
      • Financial Performance
    • Medline Industries
      • Advanced Wound Care Products
        • Revitalon
      • Current Alliances
        • Anika Therapeutics
          • Liventa Bioscience
          • Derma Sciences
          • Avery Dennison Medical
          • AcryMed
          • Lohmann & Rauscher
          • Dr Suwelack Skin & Health Care
        • Litigation with MiMedx
    • Medtronic (Covidien)
      • Advanced Wound Care Products
    • Mölnlycke Health Care
      • Wound Care Portfolio
      • Avance NPWT Systems
        • Avance Solo NPWT System
        • Avance Flex NPWT System
        • Avance Max NPWT System
      • Mepilex Border Dressings
      • Mergers & Acquisitions
        • Gerromed's woundEL Electrical Stimulation Technology
        • Brennen Medical's Burn and Wound Care Business
      • Alliance with Medela
      • Financial Performance
    • Smith & Nephew
      • Advanced Wound Care Products
        • NPWT
        • Moist Wound Care
      • Advanced Wound Bioactives
      • Current Alliances
        • UDL Laboratories
        • Lescarden/Valeant Pharmaceuticals
      • Litigation with ConvaTec
      • Financial Performance
  • OTHER COMPANIES
    • Absorbest
    • ACell
    • Adocia
    • Advanced Medical Solutions
      • Key Products
      • Current Agreements
        • Acelity
        • B. Braun
      • Financial Performance
    • Advancis Medical
    • Anika Therapeutics
    • Argentum Medical
    • Arobella Medical
    • Aspen Medical Europe (Hill-Rom)
    • Avita Medical
      • Intellectual Property
      • ReCell Spray-On Skin
      • ReGenerCell
      • Agreement with Sinopharm
      • Financial Performance
    • B. Braun
    • BioCure
    • BioMonde/ZooBiotic
    • Biotec Pharmacon
      • Woulgan Biogel
    • BSN medical
    • Cardinal Health
    • Celleration
    • Collagen Matrix
    • Comvita
      • Mergers and Acquisitions
      • Joint Ventures
        • Capilano Honey
        • East Taupo Lands Trust
      • Alliances
        • Derma Sciences
        • Manuka Research Partnership
      • Financial Performance
    • Covalon Technologies
      • Financial Performance
    • Crawford Healthcare
      • Current Agreements
        • Premier
        • US Department of Veterans Affairs
        • Exciton Technologies
        • Sun Healthcare
        • Darco GmbH & Co
        • Flen Pharma
    • DermaRite Industries
    • Derma Sciences
      • Advanced Wound Care Products
        • AMNIOEXCEL and AMNIOMATRIX
      • Current Alliances and Licensing Agreements
        • Premier
        • US Veterans Administration
        • BioDLogics
        • Quick-Med Technologies
        • Comvita
      • Financial Performance
        • Outlook
    • DeRoyal
    • Devon Medical Products
    • Eucare Pharmaceuticals
    • Ferris
    • First Water
    • Genadyne Biotechnologies
    • Gentell
    • Halyard (Kimberly-Clark)
    • Hollister Wound Care
    • Human BioSciences
    • Hydrofera
    • Innocoll
      • In Development - Cogenzia (INL-002)
    • Integra LifeSciences Holdings
      • New Products
        • Integra Omnigraft Dermal Regeneration Matrix
      • Agreement with Vomaris Wound Care
    • Integrated Healing Technologies
      • Kaken Pharmaceutical
      • Kikgel
      • Lescarden
      • Liventa Bioscience
        • Alliances
          • Medline Industries
          • Musculoskeletal Transplant Foundation
        • Litigation with MiMedx
    • Lohmann & Rauscher
    • Medela
    • Medestea Internazionale
    • MediWound
      • NexoBrid
      • EscharEx
    • MedSkin Solutions Dr. Suwelack
    • Milliken Chemical
    • MiMedx Group
      • FDA Letter
      • Litigation with Liventa Bioscience, Medline Industries and Musculoskeletal Transplant Foundation
      • Financial Performance
    • Misonix
      • Financial Performance
    • NanoVibronix
    • Noble Biomaterials
    • Nuo Therapeutics
      • Aurix System
    • Oculus Innovative Sciences
      • Financial Performance
    • Olympus Terumo Biomaterials
    • Organogenesis
    • Osiris Therapeutics
      • In Development - OTI-15-01
    • Phytoceuticals
    • PolyNovo Biomaterials
      • NovoSorb BTM
        • NovoSorb BTM for Surgical Wounds
        • NovoSorb BTM for Burns
      • NovoPore NovoSorb TNP Dressing
    • Promethean LifeSciences
    • Prospera
    • RegeneRx Biopharmaceuticals
      • RGN-137
      • Current Alliances
        • GtreeBNT
        • Lee's Pharmaceutical
        • US National Institutes of Health
    • Regenesis Biomedical
    • Sangui BioTech International
    • SanoMed Manufacturing
    • SANUWAVE Health
      • Patents
      • dermaPACE
        • PMA Studies
      • Financial Performance
    • Söring
    • Southwest Technologies
    • Synapse Electroceutical
    • Talley Group
    • Taxus Cardium Pharmaceuticals
      • Excellagen
      • Research & Development
    • The Medical & WoundCare Company
    • Tissue Regeneration Technologies
    • Triticum
    • UDL Laboratories
    • ULURU
      • Altrazeal
    • Urgo
    • Vericel
    • Vibrant Medical
    • Vomaris Innovations
      • Current Alliances
        • Integra LifeSciences
        • Metrex
        • Arthrex
    • Wound Management Technologies
      • Agreement with Applied Nutritionals
      • Financial Performance

APPENDICES

  • APPENDIX 1 - LIST OF ABBREVIATIONS
  • APPENDIX 2 - REPORT METHODOLOGY
    • Secondary Sources
    • Market forecasts

List of Tables

  • Advanced Wound Care Market by Product Type, 2011-2015 (US$ million)
  • Advanced Wound Care Market Growth by Product, 2011-2015 (%)
  • Advanced Wound Care Market by Region, 2011-2015 (US$ million)
  • Select Manufacturers' Advanced Wound Care Sales, 2009-2015 (US$ million)
  • Non-US Manufacturers' Wound Care Sales in Reported Currency, 2009-2015 (million)
  • Advanced Wound Care Acquisitions, 2008-2015
  • Advanced Wound Care Market Forecast, 2015-2020E (US$ million)
  • Global Advanced Wound Care Market Growth by Product, 2015-2020E (%)
  • Current Challenges and Opportunities in the NPWT Market
  • Moist Wound Care Market by Product Type, 2007-2015 (US$ million)
  • Moist Wound Care Market Growth, 2009-2015 (%)
  • Key Hydrogel Products and Manufacturers
  • Key Hydrocolloid Products and Manufacturers
  • Key Alginate Products and Manufacturers
  • Key Foam Products and Manufacturers
  • Key Composite Products and Manufacturers
  • Key Charcoal Products and Manufacturers
  • Key Transparent Film Products and Manufacturers
  • Key Silver Products and Manufacturers
  • Recent Key Events
  • Acelity/Centaur Guernsey- Operating Results, 2011-2015 (US$ million)
  • Acelity/Centaur Guernsey - Revenue by Region, 2014-2015 (US$ million)
  • Acelity/Centaur Guernsey - Advanced Wound Therapeutics Revenue by Type, 2011-2015 (US$ million)
  • Coloplast - Operating Results, Fiscal 2011-2015 (DKr million)
  • Coloplast - Revenue by Product Line, Fiscal 2011-2015 (DKr million)
  • Recent Key Events
  • ConvaTec - Operating Results, 2011-2015 (US$ thousands)
  • Hartmann - Operating Results, 2011-2015 (EUR million)
  • Recent Key Events
  • Mölnlycke - Operating Results, 2011-2015 (EUR million)
  • Recent Key Events
  • S&N - Operating Results, 2011-2015 (US$ million)
  • S&N Advanced Wound Management Sales by Product Line, 2011-2015 (US$ million)
  • AMS - Operating Results, 2011-2015 (£ million)
  • AMS - External Sales by Division, 2011-2015 (£ million)
  • Recent Key Events
  • Avita Medical/C3 - Operating Results, Fiscal 2011-2015 (A$ thousand)
  • Avita Medical - Sales of Goods by Region, Fiscal 2011-2015 (A$ thousand)
  • Comvita - Operating Results, 2012-2016 (NZ$ million)
  • Covalon Technologies - Operating Results, Fiscal 2011-2015 (C$ million)
  • Recent Key Events
  • Recent Key Events
  • Derma Sciences - Operating Results, 2011-2015 (US$ million)
  • Derma Sciences - Advanced Wound Care Division Results, 2011-2015 (US$ thousand)
  • Oculus - Operating Results, 2011-2015 (US$ thousand)
  • SANUWAVE Health - Operating Results, 2011-2015 (US$ thousand)
  • Wound Management Technologies - Operating Results, 2011-2015 (US$ thousand)

List of Charts

  • Fig.1: Global Wound Care Market by Product Type, 2015
  • Fig.2: Advanced Wound Care Market by Product Type, 2015
  • Fig.3: Advanced Wound Care Market by Region, 2015
  • Fig.4: Advanced Wound Care Market Shares, 2015
  • Fig.5: Advanced Wound Care Market by Product Type, 2015
  • Fig.6: Advanced Wound Care Market by Product Type, 2020E
  • Fig.7: NPWT Market Share by Company, 2015
  • Fig.8: NPWT Market, 2006-2020E (US$ million)
  • Fig.9: Misonix: SonicOne Sales, Fiscal 2007-2015 (US$ million)
  • Fig.10: Moist Wound Care Market, 2007-2020E (US$ million)
  • Fig.11: Moist Wound Care Market, 2007-2015 (US$ million)
  • Fig.12: Moist Wound Care Market by Region, 2015
  • Fig.13: Antimicrobial Wound Care Market, 2007-2015 (US$ million)
  • Fig.14: Wound Care Biologics Market, 2009-2020E (US$ million)
  • Fig.15: Wound Care Biologics Market Growth, 2010-2020E (%)
  • Fig.16: Biologics Market by Region, 2015
  • Fig.17: Cytomedix: Aurix/AutoloGel Product Sales, 2005-2014 (US$ thousand)
  • Fig.18: Acelity - Revenue by Division, 2015
  • Fig.19: Acelity - Advanced Wound Therapeutics Revenue by Type, 2015
  • Fig.20: Coloplast: Percentage of Revenue by Product Line, Fiscal 2015
  • Fig.21: Coloplast - Wound & Skin Care Revenue, Fiscal 2003-2015 (DKr million)
  • Fig.22: ConvaTec: Percentage of Revenue by Product Line, 2015
  • Fig.23: Hartmann - Revenue by Division, 2015
  • Fig.24: S&N Sales by Product Type, 2015
  • Fig.25: S&N Sales by Region, 2015
  • Fig.26: S&N Advanced Wound Management Sales by Product Type, 2015
  • Fig.27: AMS - Revenue by Division, 2015
  • Fig.28: Avita Medical - Sales of Goods by Region, Fiscal 2015
  • Fig.29: Comvita - Revenue by Division, Fiscal 2016*
  • Fig.30: Covalon Technologies: Advanced Wound Care Product Sales, Fiscal 2006-2015 (C$)
  • Fig.31: Derma Sciences - Net Sales by Division, 2015
  • Fig.32: Misonix: SonicOne Sales, Fiscal 2007-2015 (US$ million)
  • Fig.33: Nuo Therapeutics: Aurix/AutoloGel Product Sales, 2005-2014 (US$ thousand)
Back to Top